[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
[ Mon, Aug 28th 2023 ]: WOPRAI
Salim Syed Reiterated (BBIO) at Strong Buy and Held Target at $60 on, Aug 28th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Salim Syed of Mizuho, Reiterated "BridgeBio Pharma, Inc." (BBIO) at Strong Buy and Held Target at $60 on, Aug 28th, 2023.
Salim has made no other calls on BBIO in the last 4 months.
There are 4 other peers that have a rating on BBIO. Out of the 4 peers that are also analyzing BBIO, 1 agrees with Salim's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Eun Yang of "Jefferies" Downgraded from Strong Buy to Hold and Increased Target to $33 on, Tuesday, July 18th, 2023
These are the ratings of the 3 analyists that currently disagree with Salim
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $38 on, Thursday, August 17th, 2023
- Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $46 on, Tuesday, July 18th, 2023
- Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $50 on, Tuesday, July 18th, 2023